🇰🇷 TRASTUZUMAB DERUXTECAN in South Korea

TRASTUZUMAB DERUXTECAN (TRASTUZUMAB DERUXTECAN) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

TRASTUZUMAB DERUXTECAN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TRASTUZUMAB DERUXTECAN approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for TRASTUZUMAB DERUXTECAN in South Korea?

Marketing authorisation holder not available in our data.